Clarity Pharmaceuticals Ltd.ASX: CU6

Phase III CLARIFY trial in prostate cancer commences

Nov 30, 2023 at 4:11 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment